cardiovascular-agents has been researched along with Hypoglycemia* in 5 studies
1 review(s) available for cardiovascular-agents and Hypoglycemia
Article | Year |
---|---|
Glucagon: hormone or therapeutic agent?
Glucagon is an important therapeutic agent in critical care medicine. Although its endogenous hormonal functions have been well described, its clinical uses are rarely discussed. Glucagon is effective in the treatment of hypoglycemia, cardiogenic shock and heart failure, propranolol overdose, esophageal meat impaction, ureteral colic due to calculi, and acute diverticulitis. It may prove useful in the treatment of endotoxin and hypovolemic shock as well as toxicity due to excesses of procainamide, quinidine, or ouabain. Topics: Cardiotonic Agents; Cardiovascular Agents; Colic; Diverticulitis; Esophagus; Glucagon; Heart Diseases; Heart Rate; Humans; Hypoglycemia; Muscle, Smooth; Myocardial Contraction; Peristalsis; Ureteral Calculi | 1984 |
4 other study(ies) available for cardiovascular-agents and Hypoglycemia
Article | Year |
---|---|
Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus.
To evaluate the effects of indomethacin on blood glucose values in premature infants with patent ductus arteriosus (PDA).. Twenty-five very low birthweight infants with PDA were given 0.2 mg/kg, i.v., indomethacin for up to three doses. We examined the relationship between blood glucose values and glucose infusion rate before and after indomethacin therapy.. There was a significant reduction in blood glucose values between 12 and 96 h following i.v. indomethacin therapy. Eleven of 25 infants (44%) had blood glucose values below 40 mg/dL between 12 and 60 h (mean 32.7 h) after the initial dose. Although the glucose infusion rate during the first 12 h was constant (3.56 +/- 0.98 mg/kg per min), the blood glucose values decreased from 96 +/- 32 mg/dL at the starting point to 75 +/- 29 mg/dL at 12 h (P < 0.05). The maximum blood glucose reduction was 51.6 +/- 34.7 mg/dL and the maximum blood glucose reduction rate was 50.4 +/- 20.2%.. The results suggest that blood glucose values should be measured at least every 6 h for 72 h until they stabilize in order to prevent unexpected hypoglycemia. Topics: Cardiovascular Agents; Ductus Arteriosus, Patent; Female; Humans; Hypoglycemia; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Retrospective Studies; Statistics, Nonparametric | 1999 |
The effects of insulin-induced hypoglycemia in patients with angina pectoris; before and after intravenous hexamethonium.
Topics: Angina Pectoris; Cardiovascular Agents; Hexamethonium; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Muscle Relaxants, Central | 1956 |
[Effect of dehydrated ergot alkaloid on hypoglycemic convulsions and death].
Topics: Cardiovascular Agents; Death; Dehydration; Ergot Alkaloids; Hypoglycemia; Hypoglycemic Agents; Seizures | 1953 |
Effect of hexamethonium on the response to insulin in animals and man.
Topics: Animals; Cardiovascular Agents; Hexamethonium; Humans; Hypoglycemia; Insulin; Male; Muscle Relaxants, Central; Pancreatic Diseases | 1952 |